Description

Buy Qsymia Capsules In Pakistan

Qsymia Capsules – It is a brand-name prescription appetite suppressant that helps patients lose weight through diet changes, behavioral changes, and exercise. Qsymia combines an appetite suppressant (phentermine) with an anticonvulsant (topiramate) that can also cause weight loss. Topiramate can have serious side effects and Qsymia is only available through selected specialty pharmacies.

QSYMIA is a combination of phentermine, a sympathetic amine anorectic, and topiramate, combined with a reduced calorie diet and increased physical activity for chronic weight management.

Qsymia Natural Ingredients:

Phentermine/topiramate (Qsymia) combines a centrally acting appetite suppressant (phentermine) with an antiepileptic agent (topiramate) in an extended-release capsule.

It is labeled for use as an adjunct to exercise and a low-calorie diet for chronic weight management in adults with a body mass index (BMI) of 27 kg/m2 or greater and minimally relevant comorbidities, or with BMI. . At least 30 kg/m2.1 Phentermine/topiramate is a controlled substance (US Food and Drug Administration [FDA] Schedule IV).

Effectiveness Of Taking Qysmia Capsules 15mg:

Combining phentermine/topiramate with a low-calorie diet results in greater weight loss than with fewer calories and increased activity. After one year of treatment, patients on the highest dose (15/92 mg) had lost an average of 11% of their body weight, and those on the lowest dose (7.5/46 mg) had lost an average of 7%. were The percentage will decrease. up to 8 percent of their weight.

• To achieve a 5% weight loss: (the threshold for clinically meaningful weight loss), three to four patients need to be treated at the lower dose and two to three patients need to be treated for an additional patient to reach this threshold. . High doses should be treated for up to 56 weeks. number needed to treat [NNT] = 3 to 4, and NNT = 2 to 3, respectively).
• To achieve a 10 percent weight loss, four to nine patients needed to be treated at the lower dose, and for one additional patient to reach this threshold, three patients needed to be treated at the higher dose for 56 weeks. (NNT = 4 to 9, and NNT = 3, respectively).

The benefit of this weight loss is unknown. Over two years, systolic and diastolic blood pressure will decrease by 3 to 5 mm Hg, and A1C levels will decrease by 0.2% to 0.4% in patients with type 2 diabetes. Circumstances It is not known whether weight loss is sustained after stopping the drug.

Are Qsymia Capsules a Good Option?

Qsymia Capsule has been shown to be a good option for weight loss in patients who are unable to lose weight with diet and exercise alone. It should not be given to patients with a history of significant heart disease, and women of childbearing age should use contraception and have regular pregnancy tests while taking phentermine/topiramate.

Qsymia Usage Precautions:

• Potential safety issues with phentermine/topiramate include nephrolithiasis, cardiac risk, and teratogenicity.
• In two 56-week randomized controlled trials with a total of more than 3,500 participants, patients taking phentermine/topiramate had no more serious adverse events than those taking placebo, with one exception.
• 1% of patients taking the highest dose. (15/92 mg) developed significant nephrolithiasis.
• Phentermine/topiramate does not increase depressive symptoms, even in patients with preexisting major depression. It does not increase the risk of arrhythmias, valve disease, or myocardial infarction, although studies to date have excluded patients with known heart problems.
• Because patients experience a dose-dependent increase in heart rate, the FDA requires postmarketing evaluation of cardiovascular safety.
• Phentermine/topiramate is an FDA pregnancy category X drug. In animal and human studies, topiramate has been associated with an increased risk of cleft lip